CN102631413B - 一种治疗痤疮的中药组合物 - Google Patents
一种治疗痤疮的中药组合物 Download PDFInfo
- Publication number
- CN102631413B CN102631413B CN2012101298447A CN201210129844A CN102631413B CN 102631413 B CN102631413 B CN 102631413B CN 2012101298447 A CN2012101298447 A CN 2012101298447A CN 201210129844 A CN201210129844 A CN 201210129844A CN 102631413 B CN102631413 B CN 102631413B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- acne
- chinese medicinal
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 53
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 53
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000628997 Flos Species 0.000 claims description 15
- 239000008517 radix Trichosanthis Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 18
- 230000008961 swelling Effects 0.000 abstract description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 208000026435 phlegm Diseases 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 7
- 206010000501 Acne conglobata Diseases 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 208000020154 Acnes Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract description 2
- 241000931705 Cicada Species 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 231100000614 poison Toxicity 0.000 description 19
- 206010007247 Carbuncle Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 239000003440 toxic substance Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010040882 skin lesion Diseases 0.000 description 9
- 231100000444 skin lesion Toxicity 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010037888 Rash pustular Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000029561 pustule Diseases 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 206010011732 Cyst Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 208000031513 cyst Diseases 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 240000000203 Salix gracilistyla Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101298447A CN102631413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗痤疮的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101298447A CN102631413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗痤疮的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102631413A CN102631413A (zh) | 2012-08-15 |
CN102631413B true CN102631413B (zh) | 2013-11-06 |
Family
ID=46616092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101298447A Expired - Fee Related CN102631413B (zh) | 2012-04-28 | 2012-04-28 | 一种治疗痤疮的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102631413B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102805806B (zh) * | 2012-08-28 | 2013-09-11 | 韩非 | 一种治疗痤疮美容养颜的药物及其制备方法 |
CN103127373B (zh) * | 2013-03-06 | 2014-04-02 | 黄爱云 | 一种治疗脂溢性皮炎的中药组合物 |
CN104491345B (zh) * | 2014-12-15 | 2017-08-08 | 陈中元 | 一种治疗面部斑痘的药物及其制备 |
CN106309751A (zh) * | 2016-11-11 | 2017-01-11 | 成都悦伦商贸有限公司 | 一种用于治疗聚合型痤疮的中药组合物的制备方法 |
CN106344719A (zh) * | 2016-11-11 | 2017-01-25 | 成都悦伦商贸有限公司 | 一种用于治疗聚合型痤疮的中药组合物 |
CN106729398B (zh) * | 2016-12-22 | 2021-03-02 | 天津中医药大学 | 一种具有治疗痤疮作用的药物组合物 |
CN108245602B (zh) * | 2018-04-18 | 2021-03-09 | 张国壮 | 一种治疗皮肤病的外用中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101224287A (zh) * | 2007-12-27 | 2008-07-23 | 佟家勇 | 一种治疗痤疮的内服中药及其制备方法 |
CN101422554A (zh) * | 2008-09-03 | 2009-05-06 | 刘运波 | 一种治疗痤疮的中药 |
-
2012
- 2012-04-28 CN CN2012101298447A patent/CN102631413B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101224287A (zh) * | 2007-12-27 | 2008-07-23 | 佟家勇 | 一种治疗痤疮的内服中药及其制备方法 |
CN101422554A (zh) * | 2008-09-03 | 2009-05-06 | 刘运波 | 一种治疗痤疮的中药 |
Non-Patent Citations (4)
Title |
---|
《100首痤疮专方的用药分析》;魏辉;《中国美容医学》;20020228;第11卷(第1期);19-20 * |
《中医药治疗痤疮进展》;吴燕阳等;《中医研究》;19970630;第10卷(第3期);55-57 * |
吴燕阳等.《中医药治疗痤疮进展》.《中医研究》.1997,第10卷(第3期),55-57. |
魏辉.《100首痤疮专方的用药分析》.《中国美容医学》.2002,第11卷(第1期),19-20. |
Also Published As
Publication number | Publication date |
---|---|
CN102631413A (zh) | 2012-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
CN102872375B (zh) | 一种治疗痤疮的中药汤剂 | |
CN104740202A (zh) | 一种治疗皮肤瘙痒的中药 | |
CN105687409A (zh) | 一种砭石泥灸及其制备方法 | |
CN103272143A (zh) | 一种治疗痤疮的中药组合物 | |
CN103638475B (zh) | 一种治疗乳癖的中药喷雾剂及其制备方法 | |
CN105663980A (zh) | 一种治疗慢性胃炎的新型中药组合物及制备方法 | |
CN102670441A (zh) | 一种防治痔疮的中药香皂 | |
CN104338039A (zh) | 一种治疗慢性尿路感染的中药 | |
CN102302690B (zh) | 一种治疗放射性直肠炎的中药 | |
CN101947287B (zh) | 治疗痔疮的内服中药 | |
CN103623111B (zh) | 一种治疗荨麻疹的中药 | |
CN105561263A (zh) | 一种治疗暑湿感冒的中药组合物及其制备方法 | |
CN110638955A (zh) | 一种治疗痹症的中药组合物 | |
CN104888178A (zh) | 一种治疗小儿腹泻的中药 | |
CN104013761A (zh) | 一种治疗蛔虫性肠梗阻的中药灌洗剂 | |
CN103071142A (zh) | 一种速效气管炎外用贴 | |
CN102240384B (zh) | 一种治疗痰瘀互结型癫痫的药物及其制备方法 | |
CN102188680B (zh) | 一种治疗胃肠炎的中药 | |
CN107854633A (zh) | 治疗痛风的组合物及其制备方法 | |
CN101229297A (zh) | 一种用于治疗内外混合痔等疾病的中草药凉茶制剂 | |
CN105617288A (zh) | 一种治疗过敏性紫癜的中药组合物 | |
CN104096099A (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN103585518A (zh) | 一种治疗丘疹性荨麻疹的中药制剂 | |
CN102284026B (zh) | 一种治疗尿血的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YAO YUANJIE Free format text: FORMER OWNER: DONG BO Effective date: 20131009 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yao Yuanjie Inventor before: Dong Bo |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 274400 HEZE, SHANDONG PROVINCE TO: 274000 HEZE, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: DONG BO TO: YAO YUANJIE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20131009 Address after: 274000, No. 25, East Main Street, Cao Cheng Street office, Heze, Shandong, Caoxian Applicant after: Yao Yuanjie Address before: 274400 Shandong city of Heze province Caoxian Zhuang Miao Zhen Qing Road, No. 7 brick Applicant before: Dong Bo |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20140428 |